The effect of ubiquitin on immune response after controlled cortical impact injury

Journal of Trauma - Injury, Infection and Critical Care

Volumn 70, Issue 5, 2011, Pages 1104-1111

  Goelz, Leonie ^a   Casalis, Pablo A ^a   Thomale, Ulrich W ^b   Misch, Martin ^a  

^a Department of Neurosurgery ^*  (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Apoptosis; Controlled cortical impact; Cytokines; Exogenous ubiquitin; Immune response

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; BRAIN CORTEX; BRAIN INJURY; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MALE; MOLECULAR MECHANICS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW;

ANIMALS; BRAIN INJURIES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; IMMUNITY, INNATE; INTERLEUKIN-10; INTRACRANIAL PRESSURE; MALE; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN;

EID: 79955754826     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181e9c2f8     Document Type: Review

References (35)

1. Yan W, Wang HD, Feng XM, Ding YS, Jin W, Tang K. The expression of NF-E2-related factor 2 in the rat brain after traumatic brain injury. J Trauma. 2009;66:1431-1435.
2. Chiaretti A, Antonelli A, Genovese O, et al. Nerve growth factor and doublecortin expression correlates with improved outcome in children with severe traumatic brain injury. J Trauma. 2008;65:80-85.
3. Carlson NG, Wieggel WA, Chen J, Bacchi A, Rogers SW, Gahring LC. Inflammatory cytokines IL-1, IL-1, IL-6, and TNF impart neuroprotection to an excitotoxin through distinct pathways. J Immunol. 1999;163:3963-3968. (Pubitemid 29450925)
4. Wong J, Hoe NW, Zhiwei F, Ng I. Apoptosis and traumatic brain injury. Neurocrit Care. 2005;3:177-182. (Pubitemid 41325119)
5. Kutty BC, Pasupathy K, Mishra KP. Effects of exogenous ubiquitin on cell division cycle mutants of Schizosaccharomyces pombe. FEMS Microbiol Lett. 2005;244:187-191. (Pubitemid 40261196)
6. Broemer M, Meier P. Ubiquitin-mediated regulation of apoptosis. Trends Cell Biol. 2009;19:130-140.
7. Earle SA, Proctor KG, Patel MB, Majetschak M. Ubiquitin reduces fluid shifts after traumatic brain injury. Surgery. 2005;138:431-438. (Pubitemid 41415569)
8. Griebenow M, Casalis P, Woiciechowsky C, Majetschak M, Thomale UW. Ubiquitin reduces contusion volume after controlled cortical impact injury in rats. J Neurotrauma. 2007;24:1529-1535. (Pubitemid 47493516)
9. Majetschak M, Ponel Ies N, Hirsch T. Targeting the monocytic ubiquitin system with extracellular ubiquitin. Immunol Cell Biol. 2006;84:59-65.
10. Majetschak M, Cohn SM, Obertacke U, Proctor KG. Therapeutic potential of exogenous ubiquitin during resuscitation from severe trauma. J Trauma. 2004;56:991-999.
11. Earle SA, El-Haddad A, Patel MB, Ruiz P, Pham SM, Majetschak M. Prolongation of skin graft survival by exogenous ubiquitin. Transplantation. 2006;82:1544-1546. (Pubitemid 44967642)
12. Garcia-Covarrubias L, Manning EW III, Sorell LT, Pham SM, Majetschak M. Ubiquitin enhances the Th2 cytokine response and attenuates ischemia-reperfusion injury in the lung. Crit Care Med. 2008;36:979-982.
13. Thomale UW, Griebenow M, Kroppenstedt SN, Unterberg AW, Stover JF. Small volume resuscitation with HyperHaes improves pericontusional perfusion and reduces lesion volume following controlled cortical impact injury in rats. J Neurotrauma. 2004;21:1737-1746. (Pubitemid 39587571)
14. Whalen MJ, Carlos TM, Kochanek PM, Heineman S. Blood-brain barrier permeability, neutrophil accumulation and vascular adhesion molecule expression after controlled cortical impact in rats: a preliminary study. Acta Neurochir Suppl. 1998;71:212-214. (Pubitemid 128444400)
15. Sato M, Chang E, Igarashi T, Noble LJ. Neuronal injury and loss after traumatic brain injury: time course and regional variability. Brain Res. 2001;917:45-54. (Pubitemid 32972128)
16. Harting MT, Jimenez F, Adams SD, Mercer DW, Cox CS Jr. Acute, regional inflammatory response after traumatic brain injury: implications for cellular therapy. Surgery. 2008;144:803-813.
17. Shohami E, Gallily R, Mechoulam R, Bass R, Ben-Hur T. Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF inhibitor and an effective neuroprotectant. J Neuroimmunol. 1997;72:169-177. (Pubitemid 27062773)
18. Knoblach SM, Faden AI. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp Neurol. 1998;153:143-151. (Pubitemid 28452306)
19. Kamm K, Vanderkolk W, Lawrence C, Jonker M, Davis AT. The effect of traumatic brain injury upon the concentration of interleukin-1 beta an interleukin-10 in the rat. J Trauma. 2006;60:152-157.
20. Morganti-Kossmann MC, Satgunaseelan L, Bye N, Kossmann T. Modulation of immune response by head injury. Injury. 2007;38:1392-1400. (Pubitemid 350192405)
21. Kadhim HJ, Duchateau J, Sebire G. Cytokines and brain injury: invited review. J Intensive Care Med. 2008;23:236-249.
22. Streit W, Walter SA, Pennell NA. Reactive microgliosis. Prog Neurobiol. 1999;57:563-581. (Pubitemid 29148415)
23. Schilling M, Besselmann M, Leonhard C, Mueller M, Ringelstein EB, Kiefer R. Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol. 2003;183:25-33. (Pubitemid 37075853)
24. Lunemann A, Ullrich O, Diestel A, et al. Macrophage/microglia activation factor expression is restricted to lesion-associated microglial cells after brain trauma. Glia. 2006;53:412-419.
25. Streit W. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia. 2002;40:133-139. (Pubitemid 35337371)
26. Armbrust E, Röhl C. Time-and activation-dependency of the protective effect of microglia on astrocytes exposed to peroxide-induced oxidative stress. Toxicol In Vitro. 2008;22:1299-1404.
27. Fetler L, Amigorena S. Neuroscience. Brain under surveillance: the microglia patrol. Science. 2005;309:392-393. (Pubitemid 40994671)
28. Laird MD, Vender JR, Dhandapani KM. Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals. 2008;16:154-164. (Pubitemid 351263222)
29. Gold R, Schmied M, Giegerich G, et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest. 1994;71:219-225. (Pubitemid 24278174)
30. Bell MJ, Kochanek PM, Doughty LA, et al. Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J Neurotrauma. 1997;14:451-457. (Pubitemid 27338083)
31. Kline AE, Bolinger BD, Kochanek PM, et al. Acute systemic administration of interleukin-10 suppresses the beneficial effects of moderate hypothermia following traumatic brain injury in rats. Brain Res. 2002; 937:22-31. (Pubitemid 34521762)
32. Bethea JR, Nagashima H, Acosta MC, et al. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma. 1999;16:851-863. (Pubitemid 29491758)
33. Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizenmaier K, Eisel U. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci. 2002;22:1-7.
34. Saha RN, Liu X, Pahan K. Up-regulation of BDNF in astrocytes by TNF-alpha: a case for the neuroprotective role of cytokine. J Neuroimmune Pharmacol. 2006;1:212-222. (Pubitemid 44244127)
35. Loddick SA, Turnbull AV, Rothwell NJ. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab. 1998;18:176-179. (Pubitemid 28082514)